This contribution examines the application of near infra-red (NIR) quantum dot (QD) containing films for cholesterol detection. Water-soluble, 2-(dimethylamino)ethanthiol (DAET) protected 800 nm CdSeTe/ZnS core-shell QDs were prepared and incorporated into a chitosan film. The NIR electrogenerated chemiluminescence (ECL) of the QD/chitosan films upon reaction with H 2 O 2 co-reactant (produced as a by-product of cholesterol oxidase-catalysed oxidation of cholesterol) gave a strong ECL signal at -1.35 V vs. Ag/AgCl. The sensor displayed a linear response over the clinically relevant range (0.25 ≤ [cholesterol] ≤ 5 mM) allowing the rapid detection of cholesterol and providing a platform for future development. Significantly, this NIR emission has been shown to exhibit excellent penetrability through biological samples, and will likely be at the forefront of development in the biosensing and imaging fields for the foreseeable future.
INTRODUCTION
The burden of high cholesterol levels on healthcare services worldwide is becoming an increasing problem as over-eating and lack of exercise drive the current global obesity epidemic.
Hypercholesterolemia (total blood cholesterol concentrations above 5mM), 1 caused by a diet high in saturated fat 2 results in the accumulation of cholesterol on arterial walls, leading to hardening, thinning and chronic inflammation (atherosclerosis) 3 Patients suffering from this indisposition are at a proven risk of developing more serious cardiac related diseases such as ischaemic heart disease 4-5 , stroke 6 and peripheral vascular disease. 7 Detection of elevated cholesterol levels is therefore key in implementing a strategic health plan to reduce total cholesterol blood concentrations and minimize the risk of progression to more serious diseases. 8 Literature in this area indicates that it is the levels of high density and low density lipoproteins that are most strongly indicative of cardiovascular disease risk. [8] [9] [10] Both low levels of high density lipoproteins (HDL) and high levels of low density lipoproteins (LDL) are associated with an increased risk of CVD. 11 This is because oxidation of LDL tends to promote the development of atherosclerosis, 12 whereas HDL has a host of benefits that fight its onset. 13 Levels of these lipoproteins can be estimated via their associated cholesterol concentrations. 14 As such the requirement for accurate, robust and selective biosensors for cholesterol detection is of clear clinical importance.
A number of cholesterol detection methods based on spectrophotometric 15 , HPLC 16 and gas-liquid chromatography 17 have previously been reported. However, these tend to require expensive equipment, extensive sample preparation and suffer from poorer sensitivity and selectivity when compared to enzymatic based techniques. As such the majority of cholesterol biosensors incorporate cholesterol oxidase (ChOx) into their design and use electrochemical detection (amperometric) of hydrogen peroxide, produced as a byproduct in the ChOx-catalysed oxidation of cholesterol in the presence of oxygen. [18] [19] [20] [21] [22] The presence of ChOx infers excellent inherent selectivity, avoiding the need for lengthy sample preparation procedures and reducing costs, however, interference from other analytes present in the sample, as with any analysis, can lead to errors in interpretation.
ECL has been used extensively as a detection method in bio-sensing because of its advantages over other detection techniques. Excellent sensitivity is achieved as no light source is required, resulting in minimal background light intensity 23 , whilst scattered light and interferences from emission by impurities or other analytes is effectively eliminated. 24 Combined with the specificity of the ECL reaction, these attributes produce a technique that is ideally suited for detecting low concentration target analytes in complex matrices with a good signal to noise ratio. [25] [26] [27] [28] However, at the time of writing there does not appear to be any work based on the ECL of near-infrared (NIR) QD films for the detection of cholesterol. The benefit of such a system is that emission above 800 nm reduces signal interference from whole blood samples, an issue that can affect detection systems that use emitters in the visible region. These NIR emitters can therefore act as a gateway for development of a cholesterol sensor that can directly analyze whole blood samples with no sample pre-treatment.
In this work, we have developed a biosensor for cholesterol based on the ECL of 800 nm CdSeTe/ZnS core-shell QDs (Figure 1 ). A glassy carbon electrode (GCE) was modified with a QD/chitosan composite. Chitosan was selected as the polymer for film development due to its non-toxicity, good biocompatibility and commercial availability. [45] [46] This work has shown that these water-soluble, NIR-emitting QDs are suitable for use in ECL biosensors and could be extremely helpful in the development of novel systems that are able to detect clinically relevant analytes directly from clinical samples. They have been used to successfully develop a cholesterol detection system with a clinically-relevant linear range, minimizing the requirement for sample preparation. Ideally, this system could be used in combination with an agent that has the ability to selectively release cholesterol from HDL and LDL prior to its quantification and is an area in which future work would focus.
EXPERIMENTAL SECTION

Materials and Methods
Core-shell CdSeTe/ZnSquantum dots (Qdot® 800 ITK™ organic quantum dots, 1μM in decane) were purchased from Invitrogen. Chitosan (medium molecular weight, 75-85% deacetylated), phosphate buffered saline (PBS, pH 7.4), hydrogen peroxide, cholesterol, cholesterol oxidase (ChOx) from Streptomyces sp., 2-(dimethylamino)ethanthiol (DAET) and 25% aqueous glutaraldehyde were all purchased from Sigma-Aldrich and used as received. All other chemicals were of reagent grade quality and used as received. Human serum samples were obtained from Dublin City University following ethical approval and stored at -20°C until use.
Glassy carbon electrodes (3mm diameter)were purchased from IJ Cambria (UK). They were cleaned by successive polishing using 1, 0.3 and 0.05 μm alumina slurry, followed by sonication in ethanol and water, respectively, for 30 minutes. Measurements involving simultaneous detection of light and current utilized a CH instrument model 760D connected to a Hamamatsu H6780-20 PMT powered at -950 V.
During the ECL experiments, 1 mL sample volume was required and run time was 40 s. The cell was kept in a light-tight Faraday cage in a specially designed holder configuration where the working electrode was positioned directly above the PMT window. All electrochemical experiments were carried out using a conventional three-electrode assembly. Potentials are quoted versus Ag/AgCl using a platinum wire as counter and all measurements were made at room temperature (20°C). All other reagents used were of analytical grade, and all solutions were prepared in Milli-Q water (18 mΩ cm). ECL spectra were recorded on Ocean Optics USB2000+ CCD spectrometer using CH instriument electrochemical analyser, CH instrument model 760D.
Preparation of water soluble CdSeTe/ZnS core-shell QDs
The method followed was similar to that developed by Woelfle and Claus 47 . 0.5 mL of 0.5 M DAET in methanol was mixed with 0.25 mL of the CdSeTe/ZnS QDs in decane (1μM). Nitrogen was bubbled through the solution for 5 minutes, which was then sealed and left stirring overnight at room temperature in the dark. The QDs were then precipitated with an excess of acetone followed by centrifugation at 5000 rpm for 6 minutes. The filtrate was removed and the precipitate was re-dispersed in 0.25 mL of distilled water. These water-soluble QDs were centrifuged for a further 6 minutes at 3000 rpm to remove any impurities and then stored in darkness in the fridge.
Preparation of CdSeTe/ZnS core-shell QD-chitosan composite film
0.1% chitosan was prepared by dissolving 1.1 mg chitosan in 1 mL of 1% aqueous acetic acid.
The QD/chitosan composite was prepared by mixing aliquots of the water-soluble QDs with the chitosan solution in a 1:1 (v/v) ratio. This composite was then carefully cast onto the electroactive portion of a GCE and allowed to dry in the fridge for 1 hour in the dark.
Cholesterol and cholesterol oxidase solution preparation
5 mL of Triton X-100 and 5 mL of isopropanol were mixed and heated to 50°C. 0. The modified electrode was immersed in these solutions, which had been incubated for 60 minutes at 45⁰C to allow oxidation of cholesterol to occur. The incubation temperature was set at 45⁰C as maximum activity of Cholesterol Oxidase from Streptomyces sp. is achieved at this temperature (according to manufacturer). A scanning potential between 0 and -2 V was then applied to the modified electrodes and the ECL signal was monitored using a photomultiplier tube (PMT).
Preparation of spiked interferent samples
A 5 mM cholesterol solution was prepared in Triton X-100:isopropanol:0.1 M PBS (1:1:8) to which 10 mM urea, 10 mM glucose or 1 mg/mL citric acid was added. This solution was then incubated with ChOx as outlined above and the ECL response of the QD/chitosan film was then monitored.
Preparation of spiked and unknown human serum samples
Human serum was mixed 1 to 1 with cholesterol solutions at different concentrations containing 0.1 mg/mL ChOx. These solutions were mixed and left to incubate for 60 minutes at 45⁰C and then analyzed by ECL.
Water-soluble CdSeTe/ZnS QDs were dropcast onto the electrode and left to dry in the fridge for 1 hour. 0.05% chitosan was then dropcast on top of this film and allowed to dry in the fridge for 1 hour. This film was then incubated in 10% glutaraldehyde for 1 hour at room temperature followed by washing with distilled water. The electrode was then incubated in a 10 mg/mL solution of ChOx for 3 hours at room temperature followed by washing in PBS-Tween and distilled water. These films were then immersed in solutions of cholesterol and immediately analyzed.
RESULTS AND DISCUSSION
Characterisation of the QD/chitosan composite film. The absorption and emission profiles of the QDs are shown in Table 1 . Examination of the QDs was undertaken utilizing emission spectrometry. The emission maximum for the QDs lies at ~795 nm. This is related to the radiative recombination of electrons, which have been excited into higher energy levels of the QD following photon absorption, as they return to the ground state.
The ECL spectrum of the QDs, Fig. 2 , shows an emission peak at approximately 810 nm, ~15
nm longer than the photo-induced emission peaks of the QDs. This red shifted wavelength associated with the surface-confined electrochemical reactions leading to emission in the ECL process is most likely due to the difference in the reorganization energy of this route when compared to standard, optically-induced emission, as seen previously.
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The electrochemical characteristics of a blank GCE and the QD/chitosan films in the presence and absence of H 2 O 2 and in the presence of cholesterol were investigated using cyclic voltammetry (CV) and are shown in Fig. 3 . When no QD/chitosan film is present, no discernable peaks are observed. Following QD/chitosan film application, a peak is observed at -1.8 V vs.
Ag/AgCl in all cases. Investigations into this peak (see supplementary data) suggested it was related to a secondary reduction of the QDs themselves, which resulted in their destruction. (4)). Both of these processes result in the formation of QDs*, which will relax to the ground state accompanied by the emission of light at a wavelength determined by the band gap, and therefore size, of the QD material. In the presence of H 2 O 2 , two ECL peaks were present, which has been observed previously. 46 The initial peak, ECL-1, was shown to result from the interaction of a nanocrystal species formed due the reduction of the QDs and the co-reactants, whilst ECL-2 is produced from the interaction of the co-reactants and the assembly of QD reduced nanocrystal species. Investigations in this study, showed that ECL-2 is more sensitive to the dissolved H 2 O 2 , and thus was chosen to detect H 2 O 2 for developing ECL sensing applications of these QD/chitosan films.
ECL of the QD/chitosan composite film. Fig. 4 concentrations from 0.25 to 2 mM. This peak is closely related to the reduction process seen in the CVs at a very similar potential, indicating the two events are closely related and that ECL emission is dependent upon this process. 46 Reproducibility was improved by using small volumes, below 1.5 L of QD/chitosan which reduced the possibility of aggregation of the QDs in the film which might lead to variations in the ECL response.
Quantitative Detection of Cholesterol. In the presence of ChOx, H 2 O 2 is produced as a byproduct of cholesterol oxidation and can then act as a co-reactant for the production of QD ECL, in the reactions described previously (equations 1 -6). As a linear ECL response to H 2 O 2 has been achieved, it is proposed that QD/chitosan film ECL could be used for the quantitative detection of cholesterol. Fig. 5 shows the ECL response of the QD/chitosan films to increasing cholesterol concentrations.
The ECL signal shows a linear dependence over the range 0.25-5 mM cholesterol. The ECL spectrum is consistent with those acquired using H 2 O 2 co-reactant, as shown in Fig. 4 . This indicates that H 2 O 2 is successfully being produced at a concentration dependent upon the cholesterol concentration and can therefore be utilized to monitor cholesterol concentration. As such, an increase in ECL intensity is seen with an increase in total cholesterol concentration.
Above 5 mM, the ECL response deviates from linearity; however this is above the medical cutoff for high cholesterol. 8 The response from multiple biosensors was investigated to determine the reproducibility of this system and is shown in Fig. 6 .
This shows a reproducible linear response to increasing cholesterol concentrations from three independent biosensors, highlighting the consistent behaviour of this system. QD stability over a three week period was examined to give an indication of the shelf-life of this biosensor (supplementary information, Fig. S2 ). A consistent ECL response from the QDs is apparent over the considered period, with a drop in intensity of only 5.2% after three weeks. Response variability increases at the three week point, indicating biosensor reproducibility may suffer after this time.
In order to determine the clinical viability and cross-reactivity of this system, the influence of interferents commonly found in clinical samples (glucose, urea, citric acid) on the ECL response of this biosensor in 5 mM cholesterol is shown in Fig. 7 .
None of these had any appreciable effect on the observed ECL intensity indicating good sensor specificity. Therefore, human serum samples were spiked with increasing cholesterol concentrations and the response of the QD/chitosan film in each sample was measured (Fig. 8) .
A linear range from 1.5 to 4.5 mM cholesterol was examined and the ECL responses were used to quantify cholesterol in spiked serum samples. These results show that this specific system can be used to determine cholesterol concentrations from human serum samples, confirming the viability of this biosensor. In order to progress the development of this sensor, the incubation step was removed and evaluation of the QD film ECL response following immobilization of ChOx on the electrode surface was investigated. Figure 9 shows the response of these QD/chitosan/ChOx films to increasing [Cholesterol] x 10 -3 / M [Cholesterol] x 10 -3 / M
